182 related articles for article (PubMed ID: 9545576)
1. Lymphatic uptake and biodistribution of liposomes after subcutaneous injection . IV. Fate of liposomes in regional lymph nodes.
Oussoren C; Velinova M; Scherphof G; van der Want JJ; van Rooijen N; Storm G
Biochim Biophys Acta; 1998 Mar; 1370(2):259-72. PubMed ID: 9545576
[TBL] [Abstract][Full Text] [Related]
2. Role of macrophages in the localisation of liposomes in lymph nodes after subcutaneous administration.
Oussoren C; Storm G
Int J Pharm; 1999 Jun; 183(1):37-41. PubMed ID: 10361151
[TBL] [Abstract][Full Text] [Related]
3. Lymphatic uptake and biodistribution of liposomes after subcutaneous injection: III. Influence of surface modification with poly(ethyleneglycol).
Oussoren C; Storm G
Pharm Res; 1997 Oct; 14(10):1479-84. PubMed ID: 9358565
[TBL] [Abstract][Full Text] [Related]
4. Lymphatic targeting of immuno-PEG-liposomes: evaluation of antibody-coupling procedures on lymph node macrophage uptake.
Moghimi M; Moghimi SM
J Drug Target; 2008 Aug; 16(7):586-90. PubMed ID: 18686128
[TBL] [Abstract][Full Text] [Related]
5. Morphological observations on the fate of liposomes in the regional lymph nodes after footpad injection into rats.
Velinova M; Read N; Kirby C; Gregoriadis G
Biochim Biophys Acta; 1996 Jan; 1299(2):207-15. PubMed ID: 8555266
[TBL] [Abstract][Full Text] [Related]
6. Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid compostion and lipid dose.
Oussoren C; Zuidema J; Crommelin DJ; Storm G
Biochim Biophys Acta; 1997 Sep; 1328(2):261-72. PubMed ID: 9315622
[TBL] [Abstract][Full Text] [Related]
7. Liposomes to target the lymphatics by subcutaneous administration.
Oussoren C; Storm G
Adv Drug Deliv Rev; 2001 Aug; 50(1-2):143-56. PubMed ID: 11489337
[TBL] [Abstract][Full Text] [Related]
8. Improved lymphatic targeting: effect and mechanism of synthetic borneol on lymph node uptake of 7-ethyl-10-hydroxycamptothecin nanoliposomes following subcutaneous administration.
Ye T; Wu Y; Shang L; Deng X; Wang S
Drug Deliv; 2018 Nov; 25(1):1461-1471. PubMed ID: 29902927
[TBL] [Abstract][Full Text] [Related]
9. Enhanced lymph node retention of subcutaneously injected IgG1-PEG2000-liposomes through pentameric IgM antibody-mediated vesicular aggregation.
Moghimi SM; Moghimi M
Biochim Biophys Acta; 2008 Jan; 1778(1):51-5. PubMed ID: 17936719
[TBL] [Abstract][Full Text] [Related]
10. The effect of methoxy-PEG chain length and molecular architecture on lymph node targeting of immuno-PEG liposomes.
Moghimi SM
Biomaterials; 2006 Jan; 27(1):136-44. PubMed ID: 16019063
[TBL] [Abstract][Full Text] [Related]
11. Depleting Macrophages In Vivo with Clodronate-Liposomes.
Moreno SG
Methods Mol Biol; 2018; 1784():259-262. PubMed ID: 29761405
[TBL] [Abstract][Full Text] [Related]
12. Subcutaneous administration of liposomes: a comparison with the intravenous and intraperitoneal routes of injection.
Allen TM; Hansen CB; Guo LS
Biochim Biophys Acta; 1993 Jul; 1150(1):9-16. PubMed ID: 8334142
[TBL] [Abstract][Full Text] [Related]
13. MPEG-DSPE polymeric micelle for translymphatic chemotherapy of lymph node metastasis.
Li X; Dong Q; Yan Z; Lu W; Feng L; Xie C; Xie Z; Su B; Liu M
Int J Pharm; 2015 Jun; 487(1-2):8-16. PubMed ID: 25841567
[TBL] [Abstract][Full Text] [Related]
14. Incidence and severity of herpetic stromal keratitis: impaired by the depletion of lymph node macrophages.
Bauer D; Mrzyk S; Van Rooijen N; Steuhl KP; Heiligenhaus A
Exp Eye Res; 2001 Mar; 72(3):261-9. PubMed ID: 11180975
[TBL] [Abstract][Full Text] [Related]
15. Carrier activity of sonicated small liposomes containing melphalan to regional lymph nodes of rats.
Khato J; del Campo AA; Sieber SM
Pharmacology; 1983; 26(4):230-40. PubMed ID: 6844398
[TBL] [Abstract][Full Text] [Related]
16. Biodistribution of clodronate and liposomes used in the liposome mediated macrophage 'suicide' approach.
Buiting AM; Zhou F; Bakker JA; van Rooijen N; Huang L
J Immunol Methods; 1996 Jun; 192(1-2):55-62. PubMed ID: 8699022
[TBL] [Abstract][Full Text] [Related]
17. Study on intralymphatic-targeted hyaluronic acid-modified nanoliposome: influence of formulation factors on the lymphatic targeting.
Tiantian Y; Wenji Z; Mingshuang S; Rui Y; Shuangshuang S; Yuling M; Jianhua Y; Xinggang Y; Shujun W; Weisan P
Int J Pharm; 2014 Aug; 471(1-2):245-57. PubMed ID: 24858386
[TBL] [Abstract][Full Text] [Related]
18. Novel method of greatly enhanced delivery of liposomes to lymph nodes.
Phillips WT; Klipper R; Goins B
J Pharmacol Exp Ther; 2000 Oct; 295(1):309-13. PubMed ID: 10991995
[TBL] [Abstract][Full Text] [Related]
19. Long-term amelioration of rat adjuvant arthritis following systemic elimination of macrophages by clodronate-containing liposomes.
Kinne RW; Schmidt-Weber CB; Hoppe R; Buchner E; Palombo-Kinne E; Nürnberg E; Emmrich F
Arthritis Rheum; 1995 Dec; 38(12):1777-90. PubMed ID: 8849350
[TBL] [Abstract][Full Text] [Related]
20. Macrophage depletion in the rat after intraperitoneal administration of liposome-encapsulated clodronate: depletion kinetics and accelerated repopulation of peritoneal and omental macrophages by administration of Freund's adjuvant.
Biewenga J; van der Ende MB; Krist LF; Borst A; Ghufron M; van Rooijen N
Cell Tissue Res; 1995 Apr; 280(1):189-96. PubMed ID: 7750133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
